Share this article:
Elsevier and The Cancer Moonshot Recap
In case you missed it, Elsevier hosted an event titled “the Next Giant Leap: Making The Cancer Moonshot a Reality” in Boston, MA on November 16th. The event featured a panel of experts, each approaching cancer research and care from a different perspective, who discussed the challenges ahead and ways to foster support and collaboration for the greater good.
Here are some of the key points from the evening’s successful event:
There were 100+ attendees from Dana Farber, Merrimack University, eHealth, Harvard Medical School, Boston University, GlobalCures, Novartis, MIT, Rubius Therapeutics, MN Ventures, DNA Nexus, Mass General, Brigham and Women’s, UMass Medical School, Northeastern, Kochevar Research Associates, The Leukemia and Lymphoma Society, and Boston Scientific.
Panels identified the areas most needing our attention within the broader aims of the Cancer Moonshot. These areas include improving access to and participation in clinical trails, emphasizing early detection and primary prevention, and improving our existing eHealth infrastructure.
The panel also noted that although survivorship was not specifically identified as a key area of focus by the Cancer Moonshot Blue Ribbon Panel, creating better support that meets the unique needs of cancer survivors – both medically and for their overall wellbeing — will be instrumental going forward, as more and more people each year are able to either be cured or live with cancer as a manageable, chronic illness.
Attendees and panelists found the event engaging and informative with Dr. Bradford Hesse noting, “Personally, I felt that the panel was somehow greater than the sum of its parts. …I came away with some expanded spheres of thought and learned much from all of you.”
The featured keynote speaker of the night was:
Dr. William Kaelin, Professor in the Department of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School, and Associate Director, Basic Science, for the Dana-Farber/Harvard Cancer Center
The panelists who participated were:
David Ahern, Special Advisor, HCIRB, HDRP, National Cancer Institute, Director, Program in Behavioral Informatics and eHealth, Department of Psychiatry, Brigham & Women’s Hospital, Assistant Professor of Psychology, Harvard Medical School, Boston, MA, USA
Bradford Hesse, Chief of the NCI’s Health Communication and Informatics Research Branch; Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA
Ellen Beckjord, Director, Population Health Program Design and Engagement Optimization, UPMC Health Plan, Pittsburgh, PA, USA
Mark Kelley, Betty and Earl Herr Chair in Pediatric Oncology Research; Associate Director, Herman B. Wells Center for Pediatric Research; Associate Director for Basic Science Research, Simon Cancer Center, Indiana University School of Medicine; Professor, Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Huiping Liu, Assistant Professor, Department of Pathology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA; Adjunct Associate Professor, Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Justin Lathia, Assistant Professor, Department of Cellular and Molecular Medicine (NC10), Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
Michael Birrer, Director of Medical Gynecologic Oncology, the Gynecologic Oncology Research Program, Gillette Center for Gynecologic Oncology, Medicine, at Massachusetts General Hospital, Boston
For additional information on the initiative, click here.
Want to read more? Check out these books:
Providing a bridge between informatics and oncology that is built for change, Oncology Informatics encapsulates the NCI-collected evidence into a format that is optimally useful for hospital planners, physicians, researchers, and informaticians alike as they collectively strive to accelerate progress against cancer using informatics tools.
DNA Repair in Cancer Therapy provides a comprehensive and timely reference that focuses on the translational and clinical use of DNA repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment.
Use discount code STC215 at checkout and save up to 30% on your very own copy!
Biomedicine & Biochemistry
The disciplines of biomedicine and biochemistry impact the lives of millions of people every day. Research in these areas has led to practical applications in cardiology, cancer treatment, respiratory medicine, drug development, and more. Interdisciplinary fields of study, including neuroscience, chemical engineering, nanotechnology, and psychology come together in this research to yield significant new discoveries. Elsevier’s biomedicine and biochemistry content spans a wide range of subject matter in various forms, including journals, books, eBooks, and online information services, enabling students, researchers, and clinicians to advance these fields. Learn more about our Biomedical and Biochemistry books here.